![Joan Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Joan Smith is the founder of Meliora Therapeutics, Inc., where the company was founded in 2021 and the title held is Head-Technical.
Mr. Smith is currently working at Surface Venture Management LLC as an Advisor since 2020.
Education includes an undergraduate degree from the Massachusetts Institute of Technology, conferred in 2013.
Postes actifs de Joan Smith
| Sociétés | Poste | Début |
|---|---|---|
Surface Ventures
 Surface Ventures Investment ManagersFinance Surface Ventures invests in companies located in the United States and Canada. The firm targets companies operating across a broad range of sectors and industries. It provides financing for pre-seed and seed stage capital requirements with an investment size ranging from USD 0.5 - 3 million. The firm acts as a lead investor and makes follow-on investments. | Consultant / Advisor | 01/09/2020 |
Meliora Therapeutics, Inc.
 Meliora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cancer therapies using science and machine learning | Fondateur | 01/09/2021 |
Formation de Joan Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Surface Ventures
Surface Ventures Investment ManagersFinance Surface Ventures invests in companies located in the United States and Canada. The firm targets companies operating across a broad range of sectors and industries. It provides financing for pre-seed and seed stage capital requirements with an investment size ranging from USD 0.5 - 3 million. The firm acts as a lead investor and makes follow-on investments. | Finance |
Meliora Therapeutics, Inc.
Meliora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cancer therapies using science and machine learning | Commercial Services |
